尤物视频污,99热99热99超碰,精品久久久久女少妇,少妇精品无码,日B视屏久久香色,亚洲美女午夜福利av,国产美女被操,国产九九精品,国产久久色情

Hengcheng Pharmaceutical Group Huainan Co., Ltd. is located in the Biomedical Science and Technology Park of Huainan Economic and Technological Development Zone, Anhui Province. It is a comprehensive pharmaceutical and chemical enterprise specializing in the production of synthetic active pharmaceutical ingredients (APIs), as well as tablets, capsules, and molluscicide series pesticide products. The company is recognized as a high-tech enterprise. Its predecessor was Anhui Dongsheng Pharmaceutical Co., Ltd.

The company currently has 161 employees, with about 100 holding college degrees or higher. Upholding the corporate spirit of "Perseverance, Integrity, Self-improvement, and Innovation," the company relies on high-tech products and implements an export-oriented strategy to vigorously expand both domestic and international markets, achieving sound economic and social benefits. In 2022, the company achieved sales revenue of over 82 million RMB and generated $2 million in export earnings. Due to its effective management and outstanding operational performance, Hengcheng Pharmaceutical Huainan Co., Ltd. has been consecutively awarded honors by the Huainan Municipal Government, including "Advanced Import and Export Enterprise of Huainan," "Ankang Cup Advanced Unit of Huainan," and "Advanced Work Safety Unit of Huainan." In 2010, it was also rated as an AA-level tax credit enterprise in Anhui Province.

The company's main products include: API intermediates such as niclosamide series products, 5-aminosalicylic acid, and paracetamol; solid preparations such as mesalazine enteric-coated tablets (Anjiesha), nimesulide capsules, and anti-tuberculosis combination packs; pesticide formulations such as 50% niclosamide ethanolamine salt wettable powder and 70% niclosamide wettable powder. Among these, niclosamide is one of the company's major export products. This product incorporates advanced production technology from Germany's Bayer AG, and through technological innovation, a unique production process has been developed. The process is mature, and product quality is stable. It is also a collaborative product with Bayer AG, which handles global sales agency. The product is mainly exported to over thirty countries and regions in Europe, America, Asia, and Africa, generating annual export earnings of approximately $2 million. The niclosamide series products are also highly effective molluscicides and veterinary anthelmintics, and are commercially available molluscicides internationally. Niclosamide plays a significant role in the control of endemic diseases in China and global schistosomiasis prevention efforts. It is an essential drug for preventing and treating schistosomiasis and has made active contributions to its control.

Hengcheng Pharmaceutical Group Huainan Co., Ltd. adheres to the management philosophy of "People-oriented, Quality-first," maintains a development direction focused on APIs, upholds the concept of technological innovation, strictly organizes production in accordance with GMP standards, and strives for corporate growth to contribute actively to public medication safety and social development.

We welcome motivated individuals to join Hengcheng Pharmaceutical and work together to accelerate the company's development!